Among patients with type 2 diabetes who have or are at risk for gout, the use of sodium-glucose cotransporter type 2 inhibitors vs sulfonylurea was associated with a lower incidence of gout and ...
“It’s well-established that people with type 1 diabetes (T1D) and chronic kidney disease (CKD) are at high risk of progression to kidney failure and cardiovascular events due to poor glycemic control, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SGLT2 inhibitors reduce the risks for adverse kidney and ...
Authors say this could cut harmful cardiovascular-kidney-metabolic effects of NSAIDs and glucocorticoids in people with diabetes and gout. HealthDay News — For patients with gout and type 2 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results